WF

William Michael Flanagan

ST Sirna Therapeutics: 5 patents #32 of 124Top 30%
Stanford University: 2 patents #1,252 of 5,197Top 25%
BU Board Of Trustees Leland Stanford Jr University: 1 patents #50 of 153Top 35%
SP Sunesis Pharmaceuticals: 1 patents #88 of 122Top 75%
📍 Menlo Park, CA: #888 of 3,774 inventorsTop 25%
🗺 California: #66,801 of 386,348 inventorsTop 20%
Overall (All Time): #544,183 of 4,157,543Top 15%
9
Patents All Time

Issued Patents All Time

Showing 1–9 of 9 patents

Patent #TitleCo-InventorsDate
11932854 RNA interference mediated inhibition of gene expression using short interfering nucleic acids (siNA) Mark Cancilla, James J. Cunningham, Henry J. Haringsma, Denise M. Kenski, Matthew G. Stanton +2 more 2024-03-19
11193126 RNA interference mediated inhibition of gene expression using short interfering nucleic acids (siNA) Mark Cancilla, James J. Cunningham, Henry J. Haringsma, Denise M. Kenski, Matthew G. Stanton +2 more 2021-12-07
9970005 RNA interference mediated inhibition of gene expression using short interfering nucleic acids (siNA) Mark Cancilla, James J. Cunningham, Henry J. Haringsma, Denise M. Kenski, Matthew G. Stanton +2 more 2018-05-15
9512426 Method for rapidly evaluating performance of short interfering RNA with novel chemical modifications Gabor Butora, Ian Davies, Wenlang Fu, Denise M. Kenski, Ning Qi 2016-12-06
8877439 Method for rapidly evaluating performance of short interfering RNA with novel chemical modifications Gabor Butora, Ian Davies, Wenlang Fu, Denise M. Kenski, Ning Qi 2014-11-04
6875571 NF-AT polypeptides and polynucleotides and screening methods for immunosuppressive agents Gerald R. Crabtree, Jeffrey P. Northrop, Steffan N. Ho 2005-04-05
6376524 Triphenyl compounds as interleukin-4 antagonists Kenneth J. Barr, Brian C. Cunningham, Wanli Lu, Brian Raimundo, Nathan D. Waal +3 more 2002-04-23
6352830 NF-AT polypeptides and polynucleotides and screening methods for immunosuppressive agents Gerald R. Crabtree, Jeffrey P. Northrop, Steffan N. Ho 2002-03-05
5989810 Screening methods for immunosuppressive agents Gerald R. Crabtree 1999-11-23